Gapping up
In reaction to strong earnings/guidance: DRRX +21.4%, (also announced its Epigenomic Regulator Program, and the successful completion of a Phase 1 clinical trial with the program's lead product candidate DUR-928), MDR +18%, NTRI +13.4%, XON +6.8%, CISG +6.6%, EC +6.2%, CHUY +5.4%, AZO +4.5%, NAV +3.7%, DKS +3.5%, DTSI +3.3%, THLD +3%, PBYI +2.9%, GSAT +2.8%, BBY +2.8%, ASPS +2.6%, RIGL +2.3%, HALO +1.8%, JD +1.8%, INSY +1.8%, IG +1.3%, DPLO +1.3%, CNXR +1.2%, FSIC +1.1%, SSI +1.1%, MBI +0.8%
M&A news: DATE +9.9% (announces receipt of 'going private' proposal and departure of director; proposal includes an acquisition price of $5.37 per ADR), OCN +5.2% (provides various updates; anticipates that its fourth quarter results will be impacted by a $370--$420 mln non-cash charge to write-off goodwill; has hired Moelis & Company and Barclays Capital Inc. to support the Company and to advise regarding adjustments and help explore its strategic options),
Select oil/gas related names showing strength: GDP +3.5%, PBR +2.5%, SDRL +1.9%, PWE +1.6%
Other news: ONCY +15.9% (confirms the FDA granted Orphan Drug Designation for its lead product candidate, REOLYSIN, for the treatment of primary peritoneal cancers), BIOC +8.8% (David Rimm, MD, Professor of Medicine in Medical Oncology at Yale University School of Medicine, will join the Company as a scientific advisor), TSEM +8.2% (has begun mass production of an IR sensor used by Intel (INTC)), PSTI +4% (PSTI and Hadassah Medical Center announce significant data showing PLX-R18 Cells improve bone marrow transplantation), WLT +3.4% (disclosed that it agreed to issue an aggregate of 8.65 mln shares of our common stock in exchange for $66.725 mln aggregate principal amount of 8.5% Senior Notes due 2021 held by a noteholder ), DTSI +3.3% (announced its Headphone:X technology will be available on select smartphone models from top Chinese brands Huawei, vivo, nubia and letv later this year; co also reported earnings), NBG +2.7% (cont vol surrounding Greece/EU), NSAM +2.7% (filed mixed shelf offering), ISRG +1.4% (awarded $430 mln Defense Logistics Agency contract), CBOE +1.4% (reported February 2015 average daily volume for options and futures contracts declined 22% yoy to 4.7 million), HAR +1.3% (filed for a ~839.7K share common stock shelf offering by selling stockholders), SHPG +1.3% (still checking), TASR +1.1% (announces undisclosed amount of large orders of its AXON body-worn video cameras and Evidence.com solution; notes the number of agencies on the Evidence.com platform recently surpassed 5,000), C +0.9% (announces definitive agreement to sell OneMain Financial Holdings to Springleaf Holdings (LEAF) for $4.25 billion), BBRY +0.8% (introduces BlackBerry Leap)
Analyst comments: DRRX +21.4% (upgraded to Buy from Hold at Cantor Fitzgerald), LL +3.2% (upgraded to Buy from Neutral at Janney), NXPI +1.6% (upgraded to Neutral from Sell at Goldman), GPS +1.4% (upgraded to Outperform from Mkt Perform at FBR Capital)